Literature DB >> 7821476

Subclinical operating microscope retinopathy: the use of static perimetry in its detection.

A F Arafat1, G N Dutton, W N Wykes.   

Abstract

Focal retinal pathology and dysfunction as a sequel to manifest damage due to operating microscope illumination is well recognised. We wished to determine whether retinal dysfunction could be identified in the absence of clinically visible lesions. We therefore have conducted a prospective controlled study on 36 patients undergoing cataract surgery and 27 control subjects. A Wild M690 zoom operating microscope was used for each procedure. No filters were used. The Humphrey visual field equipment was employed to determine threshold retinal sensitivity at predetermined loci above and below fixation in both groups. No clinically visible retinal lesions were seen in any patient. However, post-operative investigation revealed a statistically significant depression in retinal sensitivity at points most exposed to operating microscope illumination (p < 0.05). This was most noticeable following longer total operating times and in patients with the longest time intervals between lens extraction and completion of the procedure. It is concluded that operating microscope position and centration, and the position of the eye, should be adjusted to place the image of the illuminating element away from the foveola. Also retinal illumination should be kept to a minimum, particularly after an intraocular lens has been implanted.

Entities:  

Mesh:

Year:  1994        PMID: 7821476     DOI: 10.1038/eye.1994.111

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  2 in total

1.  Effects of ascorbic acid on UV light-mediated photoreceptor damage in isolated rat retina.

Authors:  Kazuhiro Tokuda; Charles F Zorumski; Yukitoshi Izumi
Journal:  Exp Eye Res       Date:  2007-01-12       Impact factor: 3.467

2.  Central scotoma associated with intraocular silicone oil tamponade develops before oil removal.

Authors:  E N Herbert; M Habib; D Steel; T H Williamson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-27       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.